What's breaking now, across thousands of outlets.
The HHS Office of Inspector General is seeking public comment on whether to protect payments to clinical trial participants, a move supported by research showing that compensating individuals—including those who use drugs—is essential for developing effective medical treatments.
We haven't written up this one. The Hill has the full story — the link below goes straight to it.
Knee osteoarthritis (KOA) affects more than 1 in 10 people older than 40, impairing patients' mobility and quality of life. With limited treatment options, stem cell injections have been promoted as a treatment, but clinical trial evidence of efficacy is often lacking, despite claims from clinics selling untested options.
Blocking the glycine transporter SLC6A20 restored important brain signaling and improved social, communication, and repetitive behaviors in autism-related mouse models. The treatment also worked in human brain organoids and showed lasting effects in adult mice, suggesting the brain may remain more treatable later in life than previously…
Blocking the glycine transporter SLC6A20 restored important brain signaling and improved social, communication, and repetitive behaviors in autism-related mouse models. The treatment also worked in human brain organoids and showed lasting effects in adult mice, suggesting the brain may remain more treatable later in life than previously…
For patients with advanced head and neck cancer, surgery is often the first step in treatment. Many also need radiation therapy to destroy remaining cancer cells and reduce the risk that their cancer will return. Starting radiation within six weeks of surgery gives patients the best chance of beating their cancer.
Linus Pauling was widely mocked for claiming that vitamin C could fight cancer, especially after trials using vitamin C pills showed no benefit. Researchers now know that intravenous vitamin C reaches vastly higher concentrations and can behave more like an experimental cancer drug than an ordinary supplement.
Linus Pauling was widely mocked for claiming that vitamin C could fight cancer, especially after trials using vitamin C pills showed no benefit. Researchers now know that intravenous vitamin C reaches vastly higher concentrations and can behave more like an experimental cancer drug than an ordinary supplement.
